The peptide's stability profile allows for both oral and parenteral administration, with documented biological activity through multiple delivery routes including subcutaneous, intramuscular, intraperitoneal, and oral administration
Success stories from our patients speak volumes about the remarkable changes theyve experienced
Following these guidelines is crucial, as using an incompatible diluent could cause precipitation of the drug or inactivation of the drugs therapeutic effect
Some patients experience mild fatigue during the first week of treatment, which may represent the body's healing response rather than a true side effect
Signs of infection (increasing redness, warmth, swelling, or pus) require immediate discontinuation and medical evaluation
Mention prior reactions to vitamin B12, cobalt, or injections